Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease

Introduction: Brain metastases (BM) are frequent among lung cancer patients, affecting prognosis and quality of life. The International Association for the Study of Lung Cancer (IASLC), American Thoracic Society (ATS) and European Respiratory Society (ERS) lung adenocarcinoma (LADC) classification (...

Full description

Autores:
Arrieta, Oscar
Avilés Salas, Alejandro
Cardona, Andrés Felipe
Díaz-García, Diego
Lara-Mejía, Luis
Escamilla, Ixel
Pereira García, Ariana
Caballé Pérez, Enrique
Estuardo Raez, Luis
Rolfo, Christian Diego
Costa Rosell, Rafael
Tipo de recurso:
Article of journal
Fecha de publicación:
2021
Institución:
Universidad El Bosque
Repositorio:
Repositorio U. El Bosque
Idioma:
eng
OAI Identifier:
oai:repositorio.unbosque.edu.co:20.500.12495/5572
Acceso en línea:
http://hdl.handle.net/20.500.12495/5572
https://doi.org/10.1016/j.lungcan.2021.01.023
Palabra clave:
Central nervous system metastases
Histologic grade
Adenocarcinoma subtype
Differentiation grade
Lung cancer
Rights
openAccess
License
Acceso abierto
id UNBOSQUE2_8112c523042cc6d7042e66576f4a9217
oai_identifier_str oai:repositorio.unbosque.edu.co:20.500.12495/5572
network_acronym_str UNBOSQUE2
network_name_str Repositorio U. El Bosque
repository_id_str
dc.title.spa.fl_str_mv Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease
dc.title.translated.spa.fl_str_mv Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease
title Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease
spellingShingle Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease
Central nervous system metastases
Histologic grade
Adenocarcinoma subtype
Differentiation grade
Lung cancer
title_short Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease
title_full Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease
title_fullStr Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease
title_full_unstemmed Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease
title_sort Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease
dc.creator.fl_str_mv Arrieta, Oscar
Avilés Salas, Alejandro
Cardona, Andrés Felipe
Díaz-García, Diego
Lara-Mejía, Luis
Escamilla, Ixel
Pereira García, Ariana
Caballé Pérez, Enrique
Estuardo Raez, Luis
Rolfo, Christian Diego
Costa Rosell, Rafael
dc.contributor.author.none.fl_str_mv Arrieta, Oscar
Avilés Salas, Alejandro
Cardona, Andrés Felipe
Díaz-García, Diego
Lara-Mejía, Luis
Escamilla, Ixel
Pereira García, Ariana
Caballé Pérez, Enrique
Estuardo Raez, Luis
Rolfo, Christian Diego
Costa Rosell, Rafael
dc.contributor.orcid.none.fl_str_mv Cardona, Andrés Felipe [0000-0003-3525-4126]
dc.subject.keywords.spa.fl_str_mv Central nervous system metastases
Histologic grade
Adenocarcinoma subtype
Differentiation grade
Lung cancer
topic Central nervous system metastases
Histologic grade
Adenocarcinoma subtype
Differentiation grade
Lung cancer
description Introduction: Brain metastases (BM) are frequent among lung cancer patients, affecting prognosis and quality of life. The International Association for the Study of Lung Cancer (IASLC), American Thoracic Society (ATS) and European Respiratory Society (ERS) lung adenocarcinoma (LADC) classification (IASLC/ATS/ERS) has prog-nostic impact in early-stage disease; however, its role in the advanced setting is not precise. This study aims to determine the correlation between the predominant histological subtype and the risk of developing brain me-tastases (BM) in locally advanced and metastatic (stages IIIB-IV) LADC. Methods: A total of 710 patients with LADC were treated at our institution from January 2010 to December 2017. After excluding patients with brain metastases at diagnoses (n =151), they were categorized according to the IASLC/ATS/ERS LADC classification to estimate the risk of developing brain metastases. A competing risk analysis was employed, considering death a competing risk event. Results: From 559 patients, the mean age was 59 ±13.2 years, women (52.4 %), and clinical-stage IV (79.2 %). LADC subtypes distribution was lepidic (11.6 %), acinar (37.9 %), papillary (10.2 %), micropapillary (6.8 %), and solid (33.5 %). A total of 27.0 % of patients developed BM, 32.9 % died without brain affection, and 40.0 % did not progress. The predominantly solid subtype showed the greatest probability of all subtypes for developing BM [HR 4.0; 95 % CI (1.80
publishDate 2021
dc.date.accessioned.none.fl_str_mv 2021-03-08T17:30:48Z
dc.date.available.none.fl_str_mv 2021-03-08T17:30:48Z
dc.date.issued.none.fl_str_mv 2021-01-27
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.local.none.fl_str_mv Artículo de revista
dc.type.coar.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.driver.none.fl_str_mv info:eu-repo/semantics/article
format http://purl.org/coar/resource_type/c_6501
dc.identifier.issn.none.fl_str_mv 1872-8332
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/20.500.12495/5572
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1016/j.lungcan.2021.01.023
dc.identifier.instname.spa.fl_str_mv instname:Universidad El Bosque
dc.identifier.reponame.spa.fl_str_mv reponame:Repositorio Institucional Universidad El Bosque
dc.identifier.repourl.none.fl_str_mv repourl:https://repositorio.unbosque.edu.co
identifier_str_mv 1872-8332
instname:Universidad El Bosque
reponame:Repositorio Institucional Universidad El Bosque
repourl:https://repositorio.unbosque.edu.co
url http://hdl.handle.net/20.500.12495/5572
https://doi.org/10.1016/j.lungcan.2021.01.023
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartofseries.spa.fl_str_mv Lung cancer, 1872-8332, 2021
dc.relation.uri.none.fl_str_mv https://www.sciencedirect.com/science/article/pii/S0169500221000416?via%3Dihub
dc.rights.local.spa.fl_str_mv Acceso abierto
dc.rights.accessrights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
info:eu-repo/semantics/openAccess
Acceso abierto
rights_invalid_str_mv Acceso abierto
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Elsevier
dc.publisher.journal.spa.fl_str_mv Lung cancer
institution Universidad El Bosque
bitstream.url.fl_str_mv https://repositorio.unbosque.edu.co/bitstreams/7b8bd52f-651f-449b-aa76-8ef7d7443707/download
https://repositorio.unbosque.edu.co/bitstreams/a7e02dc9-32da-4ac7-a421-61287317d4eb/download
https://repositorio.unbosque.edu.co/bitstreams/a2ee3207-287e-46fc-858d-0e43852fc0e1/download
https://repositorio.unbosque.edu.co/bitstreams/70b3fac1-d89b-40f3-af39-79e9bedc0b4c/download
bitstream.checksum.fl_str_mv d1e6b92080197832022741d81ffa626a
8a4605be74aa9ea9d79846c1fba20a33
7210a811635d1799e7c05fee5d259be7
85f7b83289805f80adf328b5c09b4ed5
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad El Bosque
repository.mail.fl_str_mv bibliotecas@biteca.com
_version_ 1808397527620255744
spelling Arrieta, OscarAvilés Salas, AlejandroCardona, Andrés FelipeDíaz-García, DiegoLara-Mejía, LuisEscamilla, IxelPereira García, ArianaCaballé Pérez, EnriqueEstuardo Raez, LuisRolfo, Christian DiegoCosta Rosell, RafaelCardona, Andrés Felipe [0000-0003-3525-4126]2021-03-08T17:30:48Z2021-03-08T17:30:48Z2021-01-271872-8332http://hdl.handle.net/20.500.12495/5572https://doi.org/10.1016/j.lungcan.2021.01.023instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquerepourl:https://repositorio.unbosque.edu.coapplication/pdfengElsevierLung cancerLung cancer, 1872-8332, 2021https://www.sciencedirect.com/science/article/pii/S0169500221000416?via%3DihubRisk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic diseaseRisk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic diseaseArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articlehttp://purl.org/coar/version/c_970fb48d4fbd8a85Central nervous system metastasesHistologic gradeAdenocarcinoma subtypeDifferentiation gradeLung cancerIntroduction: Brain metastases (BM) are frequent among lung cancer patients, affecting prognosis and quality of life. The International Association for the Study of Lung Cancer (IASLC), American Thoracic Society (ATS) and European Respiratory Society (ERS) lung adenocarcinoma (LADC) classification (IASLC/ATS/ERS) has prog-nostic impact in early-stage disease; however, its role in the advanced setting is not precise. This study aims to determine the correlation between the predominant histological subtype and the risk of developing brain me-tastases (BM) in locally advanced and metastatic (stages IIIB-IV) LADC. Methods: A total of 710 patients with LADC were treated at our institution from January 2010 to December 2017. After excluding patients with brain metastases at diagnoses (n =151), they were categorized according to the IASLC/ATS/ERS LADC classification to estimate the risk of developing brain metastases. A competing risk analysis was employed, considering death a competing risk event. Results: From 559 patients, the mean age was 59 ±13.2 years, women (52.4 %), and clinical-stage IV (79.2 %). LADC subtypes distribution was lepidic (11.6 %), acinar (37.9 %), papillary (10.2 %), micropapillary (6.8 %), and solid (33.5 %). A total of 27.0 % of patients developed BM, 32.9 % died without brain affection, and 40.0 % did not progress. The predominantly solid subtype showed the greatest probability of all subtypes for developing BM [HR 4.0; 95 % CI (1.80Acceso abiertohttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abiertoORIGINALOscarArrietaaAlejandro AvilésSalas_2021.pdfOscarArrietaaAlejandro AvilésSalas_2021.pdfapplication/pdf2682761https://repositorio.unbosque.edu.co/bitstreams/7b8bd52f-651f-449b-aa76-8ef7d7443707/downloadd1e6b92080197832022741d81ffa626aMD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://repositorio.unbosque.edu.co/bitstreams/a7e02dc9-32da-4ac7-a421-61287317d4eb/download8a4605be74aa9ea9d79846c1fba20a33MD52THUMBNAILOscarArrietaaAlejandro AvilésSalas_2021.pdf.jpgOscarArrietaaAlejandro AvilésSalas_2021.pdf.jpgimage/jpeg5775https://repositorio.unbosque.edu.co/bitstreams/a2ee3207-287e-46fc-858d-0e43852fc0e1/download7210a811635d1799e7c05fee5d259be7MD53TEXTOscarArrietaaAlejandro AvilésSalas_2021.pdf.txtOscarArrietaaAlejandro AvilésSalas_2021.pdf.txtExtracted texttext/plain58106https://repositorio.unbosque.edu.co/bitstreams/70b3fac1-d89b-40f3-af39-79e9bedc0b4c/download85f7b83289805f80adf328b5c09b4ed5MD5420.500.12495/5572oai:repositorio.unbosque.edu.co:20.500.12495/55722024-02-07 12:15:30.467restrictedhttps://repositorio.unbosque.edu.coRepositorio Institucional Universidad El Bosquebibliotecas@biteca.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